Specialised Diagnostic testing for early invasive breast cancer patients
Provision of the Oncotype DX Breast Recurrence Score test.
Buyer
Somerset NHS Foundation Trust
Value
£326,700
Published
19 Mar 2026
Closes
19 Mar 2026
Procurement details
Source
Find a Tender
Region
Somerset
Procurement method
Limited
Category
Services
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
85111800
Pathology services
Lots
Lot 1 Specialised Diagnostic testing for early invasive breast cancer patients
£326,700
Oncotype DX genomic testing for breast cancer.<br/><br/>This notice is confirmation of an award having been made based on a framework agreement and without competition.<br/><br/>The lifetime value of the contract is expected to be £326,700.00 call off order.<br/><br/>The contract dates are 14 March 2026 to 13 March 2027. <br/><br/>This is an existing service...
Delivery: Somerset
Documents
No document metadata is available for this public record.
Contains public sector information licensed under the Open Government Licence v3.0.